Daniel I. Goldberg represents public and private companies and financial institutions in connection with securities offerings, mergers and acquisitions and general corporate matters. He has particular experience handling initial public offerings, follow-on offerings, shelf-takedowns, registered directs, PIPEs and Regulation S offerings. Daniel is a market leader in advising issuers and underwriters in "at-the-market" (ATM) offerings, which are an efficient way to raise working capital, fund specific projects, fund research and development or pay off debt.

Download full bio 


  • Aura Biosciences – $86.7 Million Follow-on Offering 

  • Seabridge Gold – $105.2 Million Follow-on Offering 

  • Cerevel Therapeutics – $253.8 Million Follow-on Offering and Concurrent $345.0 Million Rule 144A Convertible Notes Offering 

  • Verona Pharma – $150 Million Follow-on Offering 

  • EyePoint Pharmaceuticals – $115.4 Million Follow-on Offering 

  • View all


  • University of Pennsylvania Law School
    JD, cum laude, 1995

  • Yeshiva University
    BS, magna cum laude, 1992

Admissions & Credentials

New Jersey

New York


  • Certified Public Accountant - Maryland

Rankings & Accolades

    Legal 500 US: Capital Markets: Equity Offerings (2013-2014)